Skip to main content

Advertisement

Log in

Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups

  • Published:
Health Care Management Science Aims and scope Submit manuscript

Abstract

This study quantifies breast cancer mortality in the presence of competing risks for complex patients. Breast cancer behaves differently in different patient populations, which can have significant implications for patient survival; hence these differences must be considered when making screening and treatment decisions. Mortality estimation for breast cancer patients has been a significant research question. Accurate estimation is critical for clinical decision making, including recommendations. In this study, a competing risks framework is built to analyze the effect of patient risk factors and cancer characteristics on breast cancer and other cause mortality. To estimate mortality probabilities from breast cancer and other causes as a function of not only the patient’s age or race but also biomarkers for estrogen and progesterone receptor status, a nonparametric cumulative incidence function is formulated using data from the community-based Carolina Mammography Registry. Based on the log(−log) transformation, confidence intervals are constructed for mortality estimates over time. To compare mortality probabilities in two independent risk groups at a given time, a method with improved power is formulated using the log(−log) transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Cancer Society (2013) Cancer facts & figures 2013. American Cancer Society, Atlanta. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index. Accessed 27 Jul 2013

  2. Maillart LM, Ivy JS, Ransom S, Diehl K (2006) Assessing dynamic breast cancer Screening policies. Oper Res 56(6):1411–1427

    Article  Google Scholar 

  3. Ivy JS (2009) Can we do better? Optimization models for breast cancer screening. Handbook of Optimization in Medicine. Springer Opt App 26:1–28

    Google Scholar 

  4. Zhang S, Ivy JS (2012) Analytic modeling of breast cancer spontaneous regression. In Proceedings of Industrial and Systems Engineering Research Conference, Orlando

  5. Chu KC, Miller BA, Feuer FJ et al (1994) A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol 47:1451–1461

    Article  Google Scholar 

  6. Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25:1683–1690

    Article  Google Scholar 

  7. Jernal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19(8):1893–1907

    Article  Google Scholar 

  8. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784–1792

    Article  Google Scholar 

  9. Berry DA, Inoue L, Shen Y et al (2006) Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 36:30–36

    Article  Google Scholar 

  10. Schairer C, Mink PJ, Carroll L, Devesa S (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96(17):1311–1321

    Article  Google Scholar 

  11. Rosenberg MA (2006) Competing risks to breast cancer mortality. J Natl Cancer Inst Monogr 36:15–19

    Article  Google Scholar 

  12. Lee S, Zelen M (2006) A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr 36:79–86

    Article  Google Scholar 

  13. Fryback DG, Stout NK, Rosenberg MA et al (2006) The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36:37–47

    Article  Google Scholar 

  14. Chiu SY, Duffy S, Yen AM et al (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19(5):1219–1228

    Article  Google Scholar 

  15. Zhang S, Ivy JS, Diehl KM, Yankaskas BC (2013) The association of breast density with breast cancer mortality in African American and white women screened in community practice. Breast Cancer Res Treat 137:273–283

    Google Scholar 

  16. Clark M, Collins R, Darby S et al (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  17. Berry DA, Cirrincione C, Henderson IC et al (2006) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295:1658–1667

    Article  Google Scholar 

  18. Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25:1683–1690

    Article  Google Scholar 

  19. Rubin DB (1974) Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66(5):688–701

    Article  Google Scholar 

  20. Rubin DB (1978) Bayesian inference for causal effects: the role of randomization. Ann Stat 6:34–58

    Article  Google Scholar 

  21. Holland PW (1986) Statistics and causal inference. J Am Stat Assoc 81(396):968–970

    Google Scholar 

  22. Morgan SL, Winship C (2007) Counterfactuals and causal inference. New York: Cambridge

  23. Mani S, Cooper GF (1999) A study in causal discovery from population-based infant birth and death records. Proceedings of the AMIA Annual Fall Symposium, Philadelphia, PA, p 315–319

  24. Landrum MB, Ayanian JZ (2001) Causal effect of ambulatory specialty care on mortality following myocardial infarction: a comparison of propensity score and instrumental variable analyses. Health Serv Outcomes Res Methodol 2:221–245

    Article  Google Scholar 

  25. Witteman JC, D’Agostino RB, Stijnen T et al (1998) G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham heart study. Am J Epidemiol 148(4):390–401

    Article  Google Scholar 

  26. Marubini E, Valsecchi MG (1995) Analysing survival data from clinical trial and observational studies. Wiley, Chichester

    Google Scholar 

  27. Breast Cancer Surveillance Consortium. Available at: http://breastscreening.cancer.gov. Accessed 30 Jun 2010

  28. ICD-9-CM Code for cause of death. Available at: http://www.ihs.gov/publicinfo/publications/trends96/96trind.pdf. Accessed 30 Jun 2010

  29. ICD-10-CM Code for cause of death. Available at: http://www.cdc.gov/nchs/data/dvs/im9_2002.pdf.pdf. Accessed 30 Jun 2010

  30. Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure time data, 2nd edn. Wiley, New York

    Book  Google Scholar 

  31. Prentice RL, Kalbfleisch JD (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541–554

    Article  Google Scholar 

  32. Pepe MS, Mori M (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737–751

    Article  Google Scholar 

  33. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706

    Article  Google Scholar 

  34. Choudhury JB (2002) Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 21:1129–1140

    Article  Google Scholar 

  35. Gray RJ (1988) A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141–1154

    Article  Google Scholar 

  36. Cheang MC, Chia SK, Voduc D et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101(10):736–750

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shengfan Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, S., Ivy, J.S., Wilson, J.R. et al. Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups. Health Care Manag Sci 17, 259–269 (2014). https://doi.org/10.1007/s10729-013-9255-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10729-013-9255-x

Keywords

Navigation